Take the Rediff Biz Quiz and find out how much you know about various Indian pharmaceutical companies.
GlaxoSmithKline Consumer Healthcare on Thursday launched a new, sugar-free, low calorie avtar of its flagship brand Horlicks for health conscious adults.
Take the Rediff Biz Quiz and find out how much you know about Indian malted beverages.
GlaxoSmithKline plc, Europe's biggest drugmaker, said on Wednesday that it was accelerating work on a possible vaccine against the deadly SARS virus but warned development would take years.
Ranbaxy Laboratories Ltd, India's top drugmaker by sales, said it expected to get US approvals for a paediatric dosage of its generic version of Augmentin, GlaxoSmithKline's blockbuster antibiotic, within a month.\n\n\n\n
Pharma major Ranbaxy Laboratories on Thursday said it has scored a legal victory with a United States court ruling that its Cefuroxime Exetil product does not infringe upon the patent rights of GlaxoSmithKline.
The much-awaited merger of Burroughs Wellcome India Ltd with GlaxoSmithKline Pharmaceuticals Ltd in the country was approved by boards of both entities on Wednesday with a swap ratio of 14:10 shares.
Joy X-1800 has a 1.76 inch screen, 750 mAh battery, 0.08MP camera.
India's top drug maker Ranbaxy Laboratories said on Tuesday its first-quarter net profit nearly tripled on booming exports of generic drugs to the United States.
In a bid to speed up the litigation process, the leading home-grown pharma company Dr Reddy's Laboratories has withdrawn its challenge against GlaxoSmithKline's "compound" patent for anti-nausea drug Zofran.
Pharma major GlaxoSmithKline Pharmaceuticals Ltd has sold its Worli plot for Rs 107.6 crore (Rs 1.08 billion) to I-Ven Realty Ltd, a joint venture between ICICI Venture Funds Management Company Ltd and Oberoi Constructions.
Sales during the quarter under review stood at Rs 9,357 crore, up 12.42 per cent, as against Rs 8,323 crore in the corresponding period of the last fiscal
FIPB had taken up these three proposals in its meeting in August, but the decision on them was kept in abeyance.
The health ministry has formed a committee to consider raising the number of drugs deemed essential and subject to price caps.
Roche has already adapted its business model in India to increase affordable access to drugs and try to stave off trouble from India's patent authorities.
The NPPA letter was issued to GSK on Wednesday.
In the quarter ended September 30, the Pirojsha Godrej-led firm recorded Rs 492 crore net sales, up 49% year-on-year
'You must remember that a career is something you can craft for yourself.' 'But if you want to be a successful leader, you need the organisation and your team to support you.' 'In order to make it all work, you need to be cognisant of the team.' 'You can't be a prima donna. These days, people don't accept that.' 'You can't ride roughshod over people.'
The FIPB, headed by Department of Economic Affairs Secretary Arvind Mayaram, discussed 30 foreign direct investment proposals, including 10 from pharma sector.
Fourth quarter earnings of blue-chips such as Infosys, TCS, Wipro, RIL and inflation data for March will dictate the trend on the bourses in a holiday-shortened week ahead, experts said.
IT major nears $100 bn m-cap, accounts for 61% of the group's combined valuation.
Forex dealers said besides a lower opening in the domestic equity market on fears of a rate hike by the Reserve Bank, higher demand for the American currency from importers put pressure on the rupee but dollar's weakness against other currencies overseas, capped the fall.
Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.
Quite a few large- and mid-cap stocks are yet to recover from the note ban, pharma, banking and rural demand-based industries among laggards.
Both competitive intensity and environmental factors are contributing to the leading oral care brand's pain points
British Prime Minister Theresa May will be in India tomorrow, but Cyrus Mistry will no longer head the Indo-UK CEO forum.
Advertising taglines such as 'Bright in studies, bright in sports' attempted to drive home the message that Bournvita, a chocolate drink, could build a child's mental and physical faculties.
Even as the Supreme Court had recently dismissed the industry's plea against prices fixed by the regulator and its timely implementation, the National Pharmaceutical Pricing Authority has asked companies to pay the overcharged dues with 15 per cent interest.
DRL launched four new products in North America during the previous quarter.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances